These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33743547)

  • 1. Ppp6c haploinsufficiency accelerates UV-induced BRAF(V600E)-initiated melanomagenesis.
    Kanazawa K; Kishimoto K; Nomura M; Kurosawa K; Kato H; Inoue Y; Miura K; Fukui K; Yamashita Y; Sato I; Tsuji H; Watanabe T; Tanaka T; Yasuda J; Tanuma N; Shima H
    Cancer Sci; 2021 Jun; 112(6):2233-2244. PubMed ID: 33743547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.
    Viros A; Sanchez-Laorden B; Pedersen M; Furney SJ; Rae J; Hogan K; Ejiama S; Girotti MR; Cook M; Dhomen N; Marais R
    Nature; 2014 Jul; 511(7510):478-482. PubMed ID: 24919155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of protein phosphatase 6 in mouse keratinocytes increases susceptibility to ultraviolet-B-induced carcinogenesis.
    Kato H; Kurosawa K; Inoue Y; Tanuma N; Momoi Y; Hayashi K; Ogoh H; Nomura M; Sakayori M; Kakugawa Y; Yamashita Y; Miura K; Maemondo M; Katakura R; Ito S; Sato M; Sato I; Chiba N; Watanabe T; Shima H
    Cancer Lett; 2015 Sep; 365(2):223-8. PubMed ID: 26054846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features.
    Fukui K; Nomura M; Kishimoto K; Tanuma N; Kurosawa K; Kanazawa K; Kato H; Sato T; Miura S; Miura K; Sato I; Tsuji H; Yamashita Y; Tamai K; Watanabe T; Yasuda J; Tanaka T; Satoh K; Furukawa T; Jingu K; Shima H
    Cancer Sci; 2022 May; 113(5):1613-1624. PubMed ID: 35247012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity.
    Maskin CR; Raman R; Houvras Y
    Sci Rep; 2022 Apr; 12(1):5573. PubMed ID: 35368039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ppp6c deficiency accelerates K-ras
    Kishimoto K; Kanazawa K; Nomura M; Tanaka T; Shigemoto-Kuroda T; Fukui K; Miura K; Kurosawa K; Kawai M; Kato H; Terasaki K; Sakamoto Y; Yamashita Y; Sato I; Tanuma N; Tamai K; Kitabayashi I; Matsuura K; Watanabe T; Yasuda J; Tsuji H; Shima H
    Cancer Med; 2021 Jul; 10(13):4451-4464. PubMed ID: 34145991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIT Suppresses BRAF
    Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ
    Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV and melanoma: the TP53 link.
    Choi YS; Fisher DE
    Cell Res; 2014 Oct; 24(10):1157-8. PubMed ID: 25033756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC.
    Luo C; Sheng J; Hu MG; Haluska FG; Cui R; Xu Z; Tsichlis PN; Hu GF; Hinds PW
    Cancer Res; 2013 Jul; 73(14):4337-48. PubMed ID: 23650282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere dysfunction in Tert knockout mice delays Braf
    Zhang J; Zhang F; Porter KI; Dakup PP; Wang S; Robertson GP; Gaddameedhi S; Zhu J
    Int J Cancer; 2024 Feb; 154(3):548-560. PubMed ID: 37727982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UVB mutagenesis differs in
    Bowman RL; Hennessey RC; Weiss TJ; Tallman DA; Crawford ER; Murphy BM; Webb A; Zhang S; La Perle KM; Burd CJ; Levine RL; Shain AH; Burd CE
    Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34210801
    [No Abstract]   [Full Text] [Related]  

  • 12. Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA.
    Hayashi K; Momoi Y; Tanuma N; Kishimoto A; Ogoh H; Kato H; Suzuki M; Sakamoto Y; Inoue Y; Nomura M; Kiyonari H; Sakayori M; Fukamachi K; Kakugawa Y; Yamashita Y; Ito S; Sato I; Suzuki A; Nishio M; Suganuma M; Watanabe T; Shima H
    Oncogene; 2015 Aug; 34(35):4647-55. PubMed ID: 25486434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
    Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X
    Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
    Webster JD; Pham TH; Wu X; Hughes NW; Li Z; Totpal K; Lee HJ; Calses PC; Chaurushiya MS; Stawiski EW; Modrusan Z; Chang MT; Tran C; Lee WP; Chalasani S; Hung J; Sharma N; Chan S; Hotzel K; Talevich E; Shain A; Xu M; Lill J; Dixit VM; Bastian BC; Dey A
    Pigment Cell Melanoma Res; 2019 Mar; 32(2):269-279. PubMed ID: 30156010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic BRAF
    Shabaneh TB; Molodtsov AK; Steinberg SM; Zhang P; Torres GM; Mohamed GA; Boni A; Curiel TJ; Angeles CV; Turk MJ
    Cancer Res; 2018 Sep; 78(17):5038-5049. PubMed ID: 30026331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A landscape of driver mutations in melanoma.
    Hodis E; Watson IR; Kryukov GV; Arold ST; Imielinski M; Theurillat JP; Nickerson E; Auclair D; Li L; Place C; Dicara D; Ramos AH; Lawrence MS; Cibulskis K; Sivachenko A; Voet D; Saksena G; Stransky N; Onofrio RC; Winckler W; Ardlie K; Wagle N; Wargo J; Chong K; Morton DL; Stemke-Hale K; Chen G; Noble M; Meyerson M; Ladbury JE; Davies MA; Gershenwald JE; Wagner SN; Hoon DS; Schadendorf D; Lander ES; Gabriel SB; Getz G; Garraway LA; Chin L
    Cell; 2012 Jul; 150(2):251-63. PubMed ID: 22817889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage.
    Mar VJ; Wong SQ; Li J; Scolyer RA; McLean C; Papenfuss AT; Tothill RW; Kakavand H; Mann GJ; Thompson JF; Behren A; Cebon JS; Wolfe R; Kelly JW; Dobrovic A; McArthur GA
    Clin Cancer Res; 2013 Sep; 19(17):4589-98. PubMed ID: 23833303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
    Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
    Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-associated mutations in protein phosphatase 6 cause chromosome instability and DNA damage owing to dysregulated Aurora-A.
    Hammond D; Zeng K; Espert A; Bastos RN; Baron RD; Gruneberg U; Barr FA
    J Cell Sci; 2013 Aug; 126(Pt 15):3429-40. PubMed ID: 23729733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
    Bonet C; Luciani F; Ottavi JF; Leclerc J; Jouenne FM; Boncompagni M; Bille K; Hofman V; Bossis G; Marco de Donatis G; Strub T; Cheli Y; Ohanna M; Luciano F; Marchetti S; Rocchi S; Birling MC; Avril MF; Poulalhon N; Luc T; Hofman P; Lacour JP; Davidson I; Bressac-de Paillerets B; Ballotti R; Marine JC; Bertolotto C
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.